Literature DB >> 15254736

An investigation of the tylosis with oesophageal cancer (TOC) locus in Iranian patients with oesophageal squamous cell carcinoma.

M Shahabi1, M R Noori Daloii, J E Langan, L Rowbottom, E Jahanzad, E Khoshbin, M Taghikhani, J K Field, J M Risk.   

Abstract

Oesophageal cancer is one of the ten leading causes of cancer mortality worldwide. Earlier loss of heterozygosity (or allelic imbalance) studies have implicated regions on chromosomes 3p, 5q, 9p, 13q, 17p, 17q, and 18q in the development of sporadic oesophageal cancer and recent data have linked the familial tylosis with oesophageal cancer (TOC) gene-containing region on chromosome 17q25 with this cancer. We have studied allelic imbalance (AI) at microsatellite markers both closely linked to and distant from the TOC gene locus in 60 sporadic squamous cell oesophageal cancers from Iran and have investigated the most likely candidate gene by mutation analysis in these tumours. Forty-four out of these 60 samples (73%) show allelic imbalance at one or more loci within or adjacent to the TOC minimal region, while the highest incidence of AI was observed at the D17S2244 and D17S2246 loci (almost 70% AI in informative cases), correlating with the TOC minimal region. Analysis of the coding regions of a candidate gene in these tumours failed to show an equivalently high incidence of mutation, although two mutations and one polymorphism were observed. These data support and extend previous observations that the TOC region of chromosome 17q25 may be involved in the aetiology of the sporadic form of oesophageal cancer from a number of different geographical populations and suggest that the causative gene may be epigenetically silenced rather than mutated.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15254736     DOI: 10.3892/ijo.25.2.389

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  7 in total

1.  Abnormalities of chromosome 17 in oesophageal cancer.

Authors:  Revendran Moodley; Anunathan Reddi; Runjan Chetty; Richard Naidoo
Journal:  J Clin Pathol       Date:  2006-10-17       Impact factor: 3.411

2.  Cytoglobin is upregulated by tumour hypoxia and silenced by promoter hypermethylation in head and neck cancer.

Authors:  R J Shaw; M M Omar; S Rokadiya; F A Kogera; D Lowe; G L Hall; J A Woolgar; J Homer; T Liloglou; J K Field; J M Risk
Journal:  Br J Cancer       Date:  2009-07-07       Impact factor: 7.640

3.  RHBDF2 mutations are associated with tylosis, a familial esophageal cancer syndrome.

Authors:  Diana C Blaydon; Sarah L Etheridge; Janet M Risk; Hans-Christian Hennies; Laura J Gay; Rebecca Carroll; Vincent Plagnol; Fiona E McRonald; Howard P Stevens; Nigel K Spurr; D Timothy Bishop; Anthony Ellis; Janusz Jankowski; John K Field; Irene M Leigh; Andrew P South; David P Kelsell
Journal:  Am J Hum Genet       Date:  2012-01-19       Impact factor: 11.025

4.  Protection from intracellular oxidative stress by cytoglobin in normal and cancerous oesophageal cells.

Authors:  Fiona E McRonald; Janet M Risk; Nikolas J Hodges
Journal:  PLoS One       Date:  2012-02-16       Impact factor: 3.240

5.  Promoter methylation of P16, RARbeta, E-cadherin, cyclin A1 and cytoglobin in oral cancer: quantitative evaluation using pyrosequencing.

Authors:  R J Shaw; T Liloglou; S N Rogers; J S Brown; E D Vaughan; D Lowe; J K Field; J M Risk
Journal:  Br J Cancer       Date:  2006-02-27       Impact factor: 7.640

6.  Aberrant expression of RAB1A in human tongue cancer.

Authors:  K Shimada; K Uzawa; M Kato; Y Endo; M Shiiba; H Bukawa; H Yokoe; N Seki; H Tanzawa
Journal:  Br J Cancer       Date:  2005-05-23       Impact factor: 7.640

7.  Uncommon Endoscopic Findings in a Tylosis Patient: A Case Report.

Authors:  Balarama K Surapaneni; Pragnan Kancharla; R Vinayek; Sudhir K Dutta; Mendel Goldfinger
Journal:  Case Rep Oncol       Date:  2019-05-23
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.